Session 1: Opening Session by Lauren Kim (Founder, Program Director, and Webmaster), Allison Kim (Associate Director and Director of Outreach), and Dr. Jason Kim (Advisor)
Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School)

The Diabetes Virtual Summer Camp 2022 celebrated its 2-year anniversary with today’s Session 1 - Opening Session where Lauren Kim (Founder, Director, and Webmaster) and Allison Kim (Associate Director and Outreach) welcomed 299 student interns from all around the world and shared our goals for the program. Our Expert Session kicked off with Session 2 - “Introduction to Diabetes,” where Dr. Jason Kim (Advisor and Professor of Molecular Medicine at University of Massachusetts Chan Medical School) discussed the different types of diabetes with diagnostic criteria, characteristic features of type 1 and type 2 diabetes, diabetic complications, the importance of glucose homeostasis with insulin action and secretion, and the major role of insulin resistance in the development of type 2 diabetes. Dr. Kim also shared his insights on how to prevent and manage type 2 diabetes using lifestyle modifications (healthy diet and exercise) and different types of drugs currently in use to treat diabetes. The Opening Session ended with many bright questions from our students. We are excited to meet our student interns from all around the world to better understand diabetes and inspire our next generation of physicians and scientists.

Diabetes Virtual Summer Camp 2022 kicks off with high school, college, graduate, and medical students, trainees, physicians, researchers, and nurses from all around the world!

Opening Session 1: Lauren Kim (Founder, Program Director, and Webmaster) welcomes our students and shares our program goals.

Opening Session 1: Allison Kim (Associate Director and Director of Outreach) welcomes our students and introduces our virtual sessions.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School).

Session 2: Introduction to Diabetes by Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine in the Division of Endocrinology, Metabolism and Diabetes at University of Massachusetts Chan Medical School, Director of the National Mouse Metabolic Phenotyping Center at UMass, and MD/PhD Admissions Committee)

Session 2 : Introduction to Diabetes by Dr. Jason Kim. Dr. Kim welcomes our DVFC Interns.

Session 2 : Introduction to Diabetes by Dr. Jason Kim. Dr. Kim interacts with the DVFC Interns.

Session 2 - Introduction to Diabetes by Dr. Jason Kim. This session introduced the topic of diabetes: different types and diagnostic criteria of diabetes, characteristic features of type 1 and type 2 diabetes, diabetic complications, the importance of glucose homeostasis and how insulin regulates our glucose levels, and insulin resistance and its role in developing type 2 diabetes. The session further discussed how to prevent and manage type 2 diabetes using lifestyle modifications (healthy diet and exercise) and different drugs used to treat diabetes.

Session 2 : Introduction to Diabetes by Dr. Jason Kim. Dr. Kim addresses questions from the DVFC Interns.

Session 2 - Introduction to Diabetes by Dr. Jason Kim. This session introduced the topic of diabetes: different types and diagnostic criteria of diabetes, characteristic features of type 1 and type 2 diabetes, diabetic complications, the importance of glucose homeostasis and how insulin regulates our glucose levels, and insulin resistance and its role in developing type 2 diabetes. The session further discussed how to prevent and manage type 2 diabetes using lifestyle modifications (healthy diet and exercise) and different drugs used to treat diabetes.

Session 3: Exercise as a Platform for the Discovery of New Therapeutics by Dr. Bruce Spiegelman (Harvard Medical School)
Session 4: Diabetes and the Heart by Dr. Ira Goldberg (New York University School of Medicine)

Today’s program continued with Session 4 - “Diabetes and the Heart” led by Dr. Ira Goldberg (Clarissa and Edgar Bronfman Jr. Professor of Medicine and Chief of the Division of Endocrinology, Diabetes, and Metabolism at the New York University School of Medicine), who shared an evolving story of diabetic heart disease and the important role of cholesterol and bad diet in atherosclerosis and macrovascular disease in diabetes. The experts kindly stayed to answer many astute questions from our students. Overall, we had exciting scientific sessions highlighting the beneficial role of irisin and exercise in brain health and the damaging effects of cholesterol and a bad diet on diabetic cardiovascular complications.

Our student interns of the Diabetes Virtual Summer Camp 2022 participated in exciting and engaging sessions with world-renowned scientists. Today’s session began with Dr. Jason Kim’s Pre-Session Q&A period where he answered many outstanding questions from his opening lecture on diabetes. The Session 3 - “Exercise as a Platform for the Discovery of New Therapeutics” was led by Dr. Bruce Spiegelman (Stanley J. Korsmeyer Professor of Cell Biology and Medicine at the Harvard Medical School and Director of Center for Metabolism and Chronic Disease at the Dana-Farber Cancer Institute), who offered insights into the important relationship between diabetes and neurodegenerative disease with irisin and exercise playing a beneficial role in brain health. This was followed by Session 4 - “Diabetes and the Heart” led by Dr. Ira Goldberg (Clarissa and Edgar Bronfman Jr. Professor of Medicine and Chief of the Division of Endocrinology, Diabetes, and Metabolism at the New York University School of Medicine), who shared an evolving story of diabetic heart disease and the important role of cholesterol and bad diet in atherosclerosis and macrovascular disease in diabetes. The experts kindly stayed to answer many astute questions from our students. Overall, we had exciting scientific sessions highlighting the beneficial role of irisin and exercise in brain health and the damaging effects of cholesterol and a bad diet on diabetic cardiovascular complications.

Session 3: Exercise as a Platform for the Discovery of New Therapeutics by Dr. Bruce Spiegelman (Dana-Farber Cancer Institute and Harvard Medical School)

Session 3: Exercise as a Platform for the Discovery of New Therapeutics by Dr. Bruce Spiegelman (Stanley J. Korsmeyer Professor of Cell Biology and Medicine at the Harvard Medical School and Director of Center for Metabolism and Chronic Disease at the Dana-Farber Cancer Institute)

Session 3: Exercise as a Platform for the Discovery of New Therapeutics by Dr. Bruce Spiegelman. Dr. Spiegelman virtually interacts with our student interns.

Session 3: Exercise as a Platform for the Discovery of New Therapeutics by Dr. Bruce Spiegelman. Dr. Spiegelman addresses questions from our interns.

Session 4: Diabetes and the Heart by Dr. Ira Goldberg (New York University School of Medicine)

Session 4: Diabetes and the Heart by Dr. Ira Goldberg (Clarissa and Edgar Bronfman Jr. Professor of Medicine and Chief of the Division of Endocrinology, Diabetes, and Metabolism at the New York University School of Medicine)

Session 4: Diabetes and the Heart by Dr. Ira Goldberg. Dr. Goldberg virtually interacts with our student interns.

Session 4: Diabetes and the Heart by Dr. Ira Goldberg. Dr. Goldberg addresses questions from our interns.

Session 5: Clues to Causes and Treatments for Diabetes and Complications by Studying Special People by Dr. George King (Harvard Medical School)
Session 6: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association)

Our student interns of the Diabetes Virtual Summer Camp 2022 participated in exciting and engaging sessions with world-renowned scientists. Today’s session began with Dr. Jason Kim’s Pre-Session Q&A period where he answered many outstanding questions from previous sessions. Session 5 - “Clues to Causes and Treatments for Diabetes and Complications by Studying Special People” was led by Dr. George King (Senior Vice President and Chief Scientific Officer at Joslin Diabetes Center and Thomas J. Beatson, Jr. Chair Professor of Medicine and Ophthalmology at Harvard Medical School). Dr. King shared impactful stories of the Joslin Medalist Study Program, recognizing people with type 1 diabetes with insulin dependence for over 50 years and studying them to identify an important role of retinol binding protein 3 as a protective factor against diabetic retinopathy.

Today’s program continued with Session 6 - “A Quest for Impact” by Dr. Robert Gabbay (Chief Scientific and Medical Officer of the American Diabetes Association, Associate Professor at Harvard Medical School, and past Chief Medical Officer and Senior Vice President at Joslin Diabetes Center). Dr. Gabbay led an interactive presentation that posed thoughtful questions and challenges surrounding diabetes care to our students and further shared inspiring stories of his winding path to an impactful career as a caring physician and passionate scientist, asking our students to pursue their dreams and goals. The experts kindly stayed to answer many bright questions from our students. Overall, we had exciting scientific sessions highlighting important clinical programs at the Joslin Diabetes Center that are identifying new treatments for diabetic complications and inspiring stories of leading a path to an impactful career in science and medicine.

Session 5: Clues to Causes and Treatments for Diabetes and Complications by Studying Special People by Dr. George King (Joslin Diabetes Center and Harvard Medical School).

Session 5: Clues to Causes and Treatments for Diabetes and Complications by Studying Special People by Dr. George King (Senior Vice President and Chief Scientific Officer at Joslin Diabetes Center, and Thomas J. Beatson, Jr. Chair Professor of Medicine and Ophthalmology at Harvard Medical School).

Session 5: Clues to Causes and Treatments for Diabetes and Complications by Studying Special People by Dr. George King. Diabetes and its complications are due to a variety of causes and present in many different ways. Using tissues such as eyes, kidneys, and arteries from people with diabetes who have either none or great deal of pathologies in these organs, we have identified potential causal and protective factors for diabetic eye, kidney and cardiovascular diseases. For example we found the elevation of a protein. VEGF, to be elevated in people with severe eye diseases and diabetes. This has led to the development of using anti-VEGF as a major approach to treat severe diabetic eye diseases.

Session 5: Clues to Causes and Treatments for Diabetes and Complications by Studying Special People by Dr. George King. Dr. King addresses questions from our interns.

Session 6: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School)

Session 6: A Quest for Impact by Dr. Robert Gabby (Chief Scientific and Medical Officer of the American Diabetes Association and Associate Professor at Harvard Medical School, and past Chief Medical Officer and Senior Vice President at Joslin Diabetes Center), wearing a white coat signed by the children with type 1 diabetes.

Session 6: A Quest for Impact by Dr. Robert Gabbay. Dr. Gabbay virtually interacts with our interns.

Session 6: A Quest for Impact by Dr. Robert Gabbay. The field of diabetes research and care is vast. As I reflect on the nearly 40-year journey, I will share the drive to improve the lives of people affected by diabetes and maximize impact. It has been a journey from the micro to the macro. Along the way, you can see the many opportunities that being involved in the world of diabetes presents for your future career journeys.

Session 6: A Quest for Impact by Dr. Robert Gabby. Dr. Gabbay addresses questions from our interns.

Session 7: Diabetes Research – from Bench to Bedside by Dr. Anath Shalev (University of Alabama at Birmingham School of Medicine)
Session 8: Obesity and Type 2 Diabetes: A Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School)

Our student interns of the Diabetes Virtual Summer Camp 2022 participated in exciting and engaging sessions with world-renowned scientists. Today’s session began with Dr. Jason Kim’s Pre-Session Q&A period where he answered many outstanding questions from previous sessions. Session 7 - “Diabetes Research – from Bench to Bedside” was led by Dr. Anath Shalev (Nancy R. and Eugene C. Gwaltney Family Endowed Chair in Juvenile Diabetes Research Professor of Medicine and Director of Comprehensive Diabetes Center at the University of Alabama at Birmingham School of Medicine). Dr. Shalev shared exciting clinical study data showing the therapeutic potential of verapamil in treating type 1 diabetes and possibly type 2 diabetes through its unexpected immunomodulatory effects.

Today’s program continued with Session 8 - “Obesity and Type 2 Diabetes: A Marriage Made in Clinic” by Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine in the Division of Endocrinology, Metabolism, and Diabetes at the University of Massachusetts Chan Medical School, Director of the National Mouse Metabolic Phenotyping Center at UMass, and MD/PhD Admissions Committee). Dr. Kim led an engaging presentation to discuss the cultural, socioeconomic, and evolutionary causes of the obesity epidemic and share his research findings on the molecular link between obesity-mediated inflammation and type 2 diabetes. He also discussed the epigenetic modification in imprinting during pregnancy by sharing recent data on the long-term effects of maternal high-fat intake on the metabolic health of offspring. Dr. Kim ended his presentation by inspiring the student interns to make the next new discoveries in type 2 diabetes. Overall, we had exciting scientific sessions highlighting the bench-to-bedside approach in translational research leading to an important discovery to treat type 1 diabetes and the complex relationship between obesity and type 2 diabetes with inflammation playing a major role in molecular link.

Session 7: Diabetes Research – from Bench to Bedside by Dr. Anath Shalev (University of Alabama at Birmingham School of Medicine)

Session 7: Diabetes Research – from Bench to Bedside by Dr. Anath Shalev (Nancy R. and Eugene C. Gwaltney Family Endowed Chair in Juvenile Diabetes Research Professor of Medicine and Director of Comprehensive Diabetes Center at the University of Alabama at Birmingham School of Medicine).

Session 7: Diabetes Research – from Bench to Bedside by Dr. Anath Shalev. Dr. Shalev virtually interacts with our interns.

Session 7: Diabetes Research – from Bench to Bedside by Dr. Anath Shalev. Dr. Shalev addesses questions fom our interns.

Session 8: Obesity and Type 2 Diabetes: A Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School)

Session 8: Obesity and Type 2 Diabetes: A Marriage Made in Clinic by Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine in the Division of Endocrinology, Metabolism, and Diabetes at the University of Massachusetts Chan Medical School, Director of the National Mouse Metabolic Phenotyping Center at UMass, and MD/PhD Admissions Committee).

Session 8: Obesity and Type 2 Diabetes: A Marriage Made in Clinic by Dr. Jason Kim. Dr. Kim virtually interacts with our interns.

Session 8: Obesity and Type 2 Diabetes: A Marriage Made in Clinic by Dr. Jason Kim. This session introduces the topic of obesity and its role in type 2 diabetes: why we are so prone to become obese and what may drive the current obesity pandemic, and hormonal regulation of body weight. The session further discusses how obesity is a major cause of type 2 diabetes, current paradigms explaining the molecular link, aging and diabetes, and the clash between diabetes and COVID-19 involving inflammation. The session ends with a discussion on lessons from the past on how we have failed to control obesity, and what we must do now and in future to prevent obesity and type 2 diabetes.

Session 8: Obesity and Type 2 Diabetes: A Marriage Made in Clinic by Dr. Jason Kim. Dr. Kim virtually interacts with our interns.

Session 8: Obesity and Type 2 Diabetes: A Marriage Made in Clinic by Dr. Jason Kim. Dr. Kim addresses questions from our interns.

Session 9: Tactical Solutions to Circumnavigate Defects Underlying Diabetes by Dr. Debbie Thurmond (City of Hope)
Session 10: Diabetes Complications: Evolving from a Glucocentric View by Dr. Sudha Biddinger (Harvard Medical School)

Our student interns of the Diabetes Virtual Summer Camp 2022 participated in more exciting and engaging sessions with world-renowned scientists. Today’s session began with Dr. Jason Kim’s Pre-Session Q&A period where he answered many outstanding questions from previous sessions. Session 9 - “Tactical Solutions to Circumnavigate Defects Underlying Diabetes” was led by Dr. Debbie Thurmond (Director of the Diabetes and Metabolism Research Institute and Ruth B. and Robert K. Lanman Chair in Gene Regulation and Drug Discovery Research Professor and Founding Chair of Molecular and Cellular Endocrinology at City of Hope). Dr. Thurmond discussed the exciting biological role of STX4 as a SNARE protein with potential anti-aging properties by improving mitochondrial function and also improving insulin-secreting b-cell function in type 1 diabetes. She also shared an exciting new diagnostic biomarker for the early detection of b-cell loss and diabetes.

Today’s program continued with Session 10 - “Diabetes Complications: Evolving from a Glucocentric View” by Dr. Sudha Biddinger (Associate Professor of Pediatrics at the Boston Children’s Hospital of Harvard Medical School and Associate Professor of Molecular Metabolism at Harvard School of Public Health). Dr. Biddinger shared the exciting science behind FMO3 and TMAO, derived from gut microbial metabolites, as mediators of metabolic dysfunction, and certain foods, such as Brussels sprouts, contain an inhibitory enzyme (DIM) that may provide benefits in diabetes. She further discussed the important role of cholesterol absorption in maintaining cholesterol homeostasis and preventing diabetic macrovascular complications. Overall, we had stimulating scientific sessions highlighting the beneficial role of SNARE proteins and DIM-containing foods in human health and the important regulation of cholesterol homeostasis to prevent diabetic complications.

Session 9: Tactical Solutions to Circumnavigate Defects Underlying Diabetes by Dr. Debbie Thurmond (City of Hope)

Session 9: Tactical Solutions to Circumnavigate Defects Underlying Diabetes by Dr. Debbie Thurmond (Director of the Diabetes and Metabolism Research Institute and Ruth B. and Robert K. Lanman Chair in Gene Regulation and Drug Discovery Research Professor and Founding Chair of Molecular and Cellular Endocrinology at City of Hope).

Session 9: Tactical Solutions to Circumnavigate Defects Underlying Diabetes by Dr. Debbie Thurmond. Dr. Thurmond interacts with our DVSC Interns.

Session 9: Tactical Solutions to Circumnavigate Defects Underlying Diabetes by Dr. Debbie Thurmond. The goal of this presentation is to elucidate unconventional strategies for treatment and reversal of type 1 and type 2 diabetes.

Session 9: Tactical Solutions to Circumnavigate Defects Underlying Diabetes by Dr. Debbie Thurmond. Dr. Thurmond addresses questions from our interns.

Session 10: Diabetes Complications: Evolving from a Glucocentric View by Dr. Sudha Biddinger (Harvard Medical School)

Session 10: Diabetes Complications: Evolving from a Glucocentric View by Dr. Sudha Biddinger (Associate Professor of Pediatrics at the Boston Children’s Hospital of Harvard Medical School and Associate Professor of Molecular Metabolism at Harvard School of Public Health)

Session 10: Diabetes Complications: Evolving from a Glucocentric View by Dr. Sudha Biddinger. Dr. Biddinger virtually interacts with our interns.

Session 10: Diabetes Complications: Evolving from a Glucocentric View by Dr. Sudha Biddinger. Dr. Biddinger addresses questions from our interns.

Session 11: MAP Kinase Phosphatases in Energy Sending and Liver Disease by Dr. Anton Bennett (Yale University School of Medicine)
Session 12: The Metabolic Syndrome in a Golgi Vesicle by Dr. Jonathan Bogan (Yale University School of Medicine), and Dr. Jason Kim (former Yale University School of Medicine) reunite at Diabetes Virtual Summer Camp 2022!
Session 13: Perturbing the Early Life Microbiome in a Model of Type 1 Diabetes by Dr. Martin Blaser (Rutgers University)

Our student interns of the Diabetes Virtual Summer Camp 2022 were treated to 3 incredible and exciting sessions with world-renowned scientists. Today’s program began with Session 11 - “MAP Kinase Phosphatases in Energy Sending and Liver Disease” led by Dr. Anton Bennett (Dorys McConnell Duberg Professor of Pharmacology and Comparative Medicine at Yale University School of Medicine, Director of Yale Center for Molecular and Systems Metabolism, and Director of Minority Affairs for Yale Graduate Program in Biological and Biomedical Sciences). Dr. Bennett discussed the important role of protein tyrosine phosphatase, MKP1, in the pathogenesis of NASH and the homeostatic balance of the cellular stress-responsive system in the liver. He also shared how MKP1 may be a therapeutic target to treat metabolic liver disease.

Today’s program continued with Session 12 - “The Metabolic Syndrome in a Golgi Vesicle” by Dr. Jonathan Bogan (Associate Professor of Medicine and Cell Biology and Associate Section Chief for Research in the Section of Endocrinology and Metabolism at Yale University School of Medicine, Director of Cell Biology Core at Yale Diabetes Research Center, and Assistant Director for Education in the Yale MD/PhD Program). Dr. Bogan shared the exciting biology behind TUG in regulating glucose metabolism and the effects of its cleavage products on energy expenditure. He also shared the potential role of TUG cleavage products on thermogenesis and the thermic effect of food.

The finale of today’s exciting program was Session 13 - “Perturbing the Early Life Microbiome in a Model of Type 1 Diabetes” by Dr. Martin Blaser (Henry Rutgers Professor of the Human Microbiome, Professor of Medicine and Microbiology, and Director of Center for Advanced Biotechnology and Medicine at Rutgers University, and Chair of Presidential Advisory Council on Combating Antibiotic-resistant Bacteria), who has authored more than 600 original articles and a popular book named, Missing Microbes, which is now translated into 20 different languages. Dr. Blaser led a story-like presentation on the importance of maternal transfer of gut microbiome and the devastating effects of early-life exposure to antibiotics as a cause of losing gut microbial diversity and the increasing prevalence of many human diseases, including diabetes. He also shared the important responsibility of future generations of physicians and scientists to restore our gut microbial diversity and the possible use of microbial analysis in future pediatric care. Overall, we had an incredible scientific program highlighting MKP1 as a potential therapeutic target to treat NASH, TUG, and its cleavage products in preventing obesity and diabetes, and restoration of gut microbial diversity in improving human health.

Session 13: Perturbing the Early Life Microbiome in a Model of Type 1 Diabetes by Dr. Martin Blaser (Rutgers University)

Session 11: MAP Kinase Phosphatases in Energy Sending and Liver Disease by Dr. Anton Bennett (Yale University School of Medicine). The liver regulates glucose and lipid metabolism, and under pathophysiological conditions such as obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) these processes become dysfunctional. Stress responses activate the hepatic MAPKs, and this is thought to impair insulin action and lipid metabolism. The MAPKs also activate the MAPK phosphatases (MKPs) which oppose their actions. How the MAPK/MKP balance is controlled in liver metabolism remains unclear. Recent advances from this lab on how the MKPs function to regulate MAPK signaling in hepatic metabolism will be discussed.

Session 11: MAP Kinase Phosphatases in Energy Sending and Liver Disease by Dr. Anton Bennett (Dorys McConnell Duberg Professor of Pharmacology and Comparative Medicine at Yale University School of Medicine, Director of Yale Center for Molecular and Systems Metabolism, and Director of Minority Affairs for Yale Graduate Program in Biological and Biomedical Sciences)

Session 11: MAP Kinase Phosphatases in Energy Sending and Liver Disease by Dr. Anton Bennett. Dr. Bennett addresses questions from our interns.

Session 12: The Metabolic Syndrome in a Golgi Vesicle by Dr. Jonathan Bogan (Yale University School of Medicine).

Session 12: The Metabolic Syndrome in a Golgi Vesicle by Dr. Jonathan Bogan (Associate Professor of Medicine and Cell Biology and Associate Section Chief for Research in the Section of Endocrinology and Metabolism at Yale University School of Medicine, Director of Cell Biology Core at Yale Diabetes Research Center, and Assistant Director for Education in the Yale MD/PhD Program)

Session 12: The Metabolic Syndrome in a Golgi Vesicle by Dr. Jonathan Bogan. Dr. Bogan virtually interacts with our interns.

Session 12: The Metabolic Syndrome in a Golgi Vesicle by Dr. Jonathan Bogan. This presentation will describe research to understand how glucose uptake is regulated in fat and muscle cells. Work in this area links diabetes pathophysiology with cell biology, particularly mechanisms to control intracellular protein targeting. Unexpectedly, observations suggested that altered protein targeting may contribute to several distinct aspects of metabolic disease.

Yale Endocrinology & Metabolism Section Faculty with Dr. Jonathan Bogan and Dr. Jason Kim in 2004!

Session 13: Perturbing the Early Life Microbiome in a Model of Type 1 Diabetes by Dr. Martin Blaser (Rutgers University).

Session 13: Perturbing the Early Life Microbiome in a Model of Type 1 Diabetes by Dr. Martin Blaser (Henry Rutgers Professor of the Human Microbiome, Professor of Medicine and Microbiology, and Director of Center for Advanced Biotechnology and Medicine at Rutgers University, and Chair of Presidential Advisory Council on Combating Antibiotic-resistant Bacteria)

Session 13: Perturbing the Early Life Microbiome in a Model of Type 1 Diabetes by Dr. Martin Blaser. Dr. Blaser virtually interacts with our interns.

Session 13: Perturbing the Early Life Microbiome in a Model of Type 1 Diabetes by Dr. Martin Blaser. I will discuss the microbiome, what it is and what it does, and then discuss why the microbiome is of interest in relation to T1D. I will discuss our model of T1D in mice and how the findings might be relevant to both human illness, and how it may provide new leads to prevention and treatment.

Session 14: Preparing for Medical School and Scientific Career by Dr. Jason Kim (University of Massachusetts Chan Medical School).

On this last day of Diabetes Virtual Summer Camp 2022, our student interns participated in the finale Session 14 – “Preparing for Medical School and Scientific Career,” where Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine in the Division of Endocrinology, Metabolism, and Diabetes at the University of Massachusetts Chan Medical School, Director of the National Mouse Metabolic Phenotyping Center at UMass, and MD/PhD Admissions Committee) discussed how high school and college students can explore their interests in medicine and science and how college curriculum and extracurricular activities can be organized to prepare for medical school. He also shared his insights from serving on the medical school admissions committee for more than 20 years (at Yale, Penn State, and UMass) by presenting an overview of the medical school admissions process, application and interview process, a glance at clinical fellowship curriculum, and a day in the life of an academic professor engaged in research, teaching, and various committees for national and international organizations.

Session 14: Preparing for Medical School and Scientific Career by Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine in the Division of Endocrinology, Metabolism, and Diabetes at the University of Massachusetts Chan Medical School, Director of the National Mouse Metabolic Phenotyping Center at UMass, and MD/PhD Admissions Committee)

Session 14: Preparing for Medical School and Scientific Career by Dr. Jason Kim. Dr. Kim addresses questions from our DVSC Interns.

Session 15: Closing Session by Lauren Kim (Founder, Program Director, and Webmaster, University of Southern California).

After 15 exciting sessions, the Diabetes Virtual Summer Camp 2022 reached the Closing Session, where Lauren Kim and Allison Kim shared heartfelt closing remarks with the story of how Diabetes Virtual Camp began, all the hard work and dedication to organize the virtual programs, what has been accomplished over the past 2 years, and their commitments for future programs to support the next generations of physicians and scientists. On behalf of the Diabetes Virtual Camp, Lauren Kim and Allison Kim expressed wholehearted appreciation to our amazing student interns from all around the world for their steadfast interests and growing passion for diabetes, biomedical research, and medicine and for their generous contributions to support diabetes research, education, and care.

In all, our Diabetes Virtual Camp and the American Diabetes Association are working together to support exciting research and important education to inspire the next generations of physicians and scientists, sharing our mission to improve diabetes care and to find a cure for diabetes.

Session 15: Closing Session by Allison Kim (Associate Director and Director of Outreach, Boston University).

Session 15: Closing Session by Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine in the Division of Endocrinology, Metabolism, and Diabetes at the University of Massachusetts Chan Medical School, Director of the National Mouse Metabolic Phenotyping Center at UMass, and MD/PhD Admissions Committee)

Session 15: Closing Session poll by student interns from all around the world.

Session 15: Closing Session poll by student interns from all around the world.

Session 15: Closing Session - Lauren Kim, Allison Kim, and Dr. Jason Kim thank our interns from around the world and “Goodbye” till the next program…